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Regulation of CO2 elimination is essential for the maintenance 
of cellular homeostasis (1). In mammals, the lung disposes of the 
excess CO2 produced by the body, and in several lung diseases the 
alveolar epithelium, the site of CO2 elimination, is exposed to 
hypercapnia. For example, in patients with exacerbation of chron-
ic obstructive pulmonary disease, it is not uncommon to observe 
pCO2 levels of 60–80 mmHg in the arterial blood, which is associ-
ated with worse outcomes (2). Furthermore, in mechanically ven-
tilated patients with acute lung injury and “permissive hypercap-
nia,” pCO2 levels are as high as 100 mmHg, and in patients with 
uncontrolled asthma pCO2, levels as high as 250 mmHg have been 
reported (3, 4). However, whether high pCO2 levels have a positive 
or negative effect on the alveolar epithelium is still the subject of 
controversy (3, 5–7).
Under physiological conditions the alveolo-capillary barrier 
function ensures optimal gas exchange while keeping the alveoli 
free of edema (8, 9). Active Na+ transport and alveolar fluid reab-
sorption (AFR), major functions of the alveolar epithelium, are 
regulated mostly by apical Na+ channels and the basolateral Na,K-
ATPase (8, 9). A decrease in the number of Na,K-ATPase molecules 
at the plasma membrane results in inhibition of Na+ transport, 
with a subsequent inhibition of alveolar fluid clearance (9–14). We 
and others have previously reported that the Na,K-ATPase endocy-
tosis is triggered by the phosphorylation of its α subunit at serine 
18 by PKC-ζ (10, 15). Thus regulation of the Na,K-ATPase endocy-
tosis represents an important mechanism that maintains optimal 
alveolar epithelial function.
The AMP-activated protein kinase (AMPK) has been proposed as 
a metabolic sensor and in response to metabolic or nonmetabolic 
stress activates energy-generating pathways while downregulating 
energy-consuming events, thereby promoting cell adaptation to 
stress (16). AMPK is a Ser/Thr kinase that is ubiquitously expressed 
and highly conserved phylogenetically, with orthologs in plants and 
yeast (17). In the mammalian epithelium, AMPK has been reported 
to inhibit the epithelial Na+ channel (ENaC) and the cystic fibrosis 
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transmembrane conductance regulator Cl– channel (18, 19). Also, 
a recent study reported that pharmacological activation of AMPK 
reduces ouabain-sensitive Na+ transport in cultured epithelial cells, 
suggesting a role for AMPK in Na,K-ATPase regulation (20).
We have recently observed that exposing the alveolar epitheli-
um to high concentrations of CO2 impaired AFR by promoting 
Na,K-ATPase endocytosis from the plasma membrane of rat 
alveolar epithelial type II (ATII) cells (21). In the present study, 
we provide evidence that a short-term elevation in pCO2 activates 
AMPK in a Ca2+- and Ca2+/calmodulin-dependent kinase kinase-β– 
dependent (CaMKK-β-dependent) manner in alveolar epithelial 
cells (AECs), leading to activation of PKC-ζ and thereby promot-
ing Na,K-ATPase endocytosis and thus impairing fluid reabsorp-
tion, a major function of the alveolar epithelium. The inhibition of 
AFR was ameliorated by the β-adrenergic agonist, isoproterenol.
Results
High CO2 levels activate AMPK in AECs. To determine whether AMPK 
was activated by high pCO2 or by the hypercapnia-associated aci-
dosis, we assessed the phosphorylation of AMPK-α subunit, which 
reflects the activation status of AMPK (22). Exposure of ATII cells 
to elevated CO2 levels (60–120 mmHg at a pHe of 7.4) for 5 min 
led to a concentration-dependent phosphorylation of AMPK at 
Thr172 (Figure 1A). The AMPK activation by high CO2 levels was 
transient (Figure 1B) and returned to baseline values after 20 min 
of CO2 exposure (data not shown). Although AMPK was not stimu-
lated by 60 mmHg CO2 within 5 min as with higher pCO2, a signifi-
cant stimulation of AMPK was found when ATII cells were exposed 
to 60 mmHg CO2 for 10–20 min, and similarly to cells exposed to 
higher CO2 levels, AMPK activity returned to baseline levels after 
30 min (data not shown). In contrast, when ATII cells were exposed 
to extracellular acidosis but normal CO2 levels (pHe 7.2 and 40 
mmHg), AMPK phosphorylation was not observed (Figure 1A). 
Since maximal activation of AMPK was achieved at approximately 
120 mmHg of CO2 at normal pH, the subsequent cellular experi-
ments with high CO2 were performed under these conditions.
CO2-induced Na,K-ATPase endocytosis is mediated by AMPK. We have 
recently observed that hypercapnia leads to AFR impairment and 
promotes Na,K-ATPase endocytosis from the plasma membrane 
to the intracellular compartments in AECs (21, 23). To determine 
whether activation of AMPK was required for the hypercapnia-
induced Na,K-ATPase endocytosis, we assessed plasma mem-
brane Na,K-ATPase protein abundance in ATII cells exposed to 
high CO2 in the presence of the AMPK inhibitor compound C. 
Exposure of cells to 120 mmHg CO2 decreased the plasma mem-
brane Na,K-ATPase α1 protein abundance by approximately 
45% without affecting the total Na,K-ATPase cell pools. This effect 
was prevented by pretreatment of the cells with compound C 
(Figure 2A). Moreover, when ATII cells were infected with an 
adenovirus expressing a dominant-negative variant of AMPK-α1 
(DN–AMPK-α1), endocytosis of the Na,K-ATPase α1 subunit was 
prevented (in contrast to ATII cells infected with the null (Ad-null) 
virus; Figure 2B). To determine whether activation of AMPK was 
sufficient to promote Na,K-ATPase endocytosis, ATII cells were 
exposed to the AMPK activator 5-aminoimidazole-4-carboxamide 
1-β-d-ribofuranoside (AICAR), which resulted in a decreased num-
ber of Na,K-ATPase molecules at the plasma membrane without 
affecting total cell Na,K-ATPase levels (Figure 2C). Furthermore, in 
ATII cells infected with an adenovirus expressing the constitutively 
active variant of AMPK-α (Ad-CA–AMPK-α), a dose-dependent 
reduction in the number of Na,K-ATPase molecules in the plasma 
membrane occurred (Figure 2D).
ROS play a key signaling role in hypoxia-induced activation of 
PKC-ζ, leading to Na,K-ATPase endocytosis and degradation (10, 
24–26). We determined whether high CO2 increased the produc-
tion of ROS in rat ATII cells. Neither cytosolic nor mitochon-
drial ROS were increased by incubating AECs to elevated pCO2 
(Supplemental Figure 1, A and B; supplemental material available 
online with this article; doi:10.1172/JCI29723DS1), in contrast to 
hypoxia, in which intracellular ROS were increased (Supplemental 
Figure 1C). Furthermore, pretreatment of ATII cells with the ROS 
scavenger Eukarion 134 did not prevent the high pCO2-induced 
Na,K-ATPase endocytosis but inhibited the H2O2-induced down-
regulation of Na,K-ATPase (Supplemental Figure 1D). These data 
suggest that ROS do not participate in the high pCO2-induced 
Na,K-ATPase endocytosis.
Figure 1
High CO2 levels activate AMPK in a concentration- and time-depen-
dent manner in ATII cells. (A) ATII cells were exposed to 40, 60, 
80, and 120 mmHg CO2 with an extracellular pH (pHe) of 7.4 (white 
and black bars) or to 40 mmHg CO2 with a pHe of 7.2 (gray bar) for 
5 min, and the phosphorylation of AMPK at Thr172 (pAMPK-α) and 
the total amount of AMPK-α was measured by Western blot analysis. 
Graph represents the pAMPK/AMPK ratio. Values are expressed as 
mean ± SEM. n = 4. Representative Western blots of pAMPK-α and 
total AMPK-α. (B) ATII cells were treated with 40 mmHg CO2 (white 
bar) for 5 min or with 120 mmHg CO2 for 15 s to 5 min (black bars) at 
a pHe of 7.4. Graph represents the pAMPK/AMPK ratio. Values are 
expressed as mean ± SEM. n = 4. Representative Western blots of 
pAMPK-α and total AMPK-α. *P < 0.05; **P < 0.01.
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AMPK activates PKC-ζ in AECs. We and others have previously 
reported that PKC-ζ phosphorylation of Na,K-ATPase leads to its 
endocytosis (10, 13, 15), and thus we examined whether PKC-ζ was 
a downstream target of AMPK. Exposure of ATII cells to elevated 
CO2 levels resulted in PKC-ζ activation, measured by a PKC-ζ 
kinase assay (Figure 3A), and translocation to the membrane 
fraction (Figures 3, C and D). Furthermore, the AMPK activator 
AICAR increased AMPK phosphorylation (data not shown) and 
led to PKC-ζ translocation (Figure 3B). The CO2-induced PKC-ζ 
translocation was prevented by compound C, or DN–AMPK-α1 
overexpression (Figure 3, C and D). In contrast, preincubation 
of AECs with a high dose of bisindolylmaleimide I, with a myris-
toylated peptide inhibitor of PKC-ζ, or with adenovirus-mediated 
overexpression of DN–PKC-ζ did not prevent the CO2-induced 
AMPK activation (Figure 3, E and F), suggesting that AMPK acts 
upstream of PKC-ζ in the CO2-induced signaling cascade.
Intracellular Ca2+ and CaMKK-β mediate the high CO2-induced activa-
tion of AMPK. We investigated whether Ca2+ signaling was involved 
in the AMPK activation upon exposure of AECs to high CO2 lev-
els. Switching the perfusion of Fura-2 acetoxymethyl ester–loaded 
(Fura-2/AM–loaded) ATII cells from media with 40–120 mmHg 
pCO2 resulted in a rapid and transient increase in intracellular Ca2+ 
([Ca2+]i) concentration (Figure 4A). Chelation of intracellular Ca2+ 
with 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid–
acetoxymethyl ester (BAPTA-AM) prevented the high CO2-induced 
phosphorylation of AMPK at Thr172 (Figure 4B), suggesting that 
intracellular Ca2+ was involved in the signaling cascade initiated by 
high pCO2. Two upstream kinases of AMPK have been identified in 
Figure 2
Activation of AMPK is both necessary and sufficient to promote Na,K-ATPase endocytosis in ATII cells. (A) ATII cells were exposed to 40 or 120 
mmHg CO2 for 30 min in the presence or absence of compound C (20 μM, 30 min preincubation). Na,K-ATPase at the plasma membrane was 
determined by biotin-streptavidin pull-down and Western blot. Representative Western blots of Na,K-ATPase-α1 at the plasma membrane (PM) 
and total protein abundance are shown. (B) ATII cells were infected with Ad-null or HA-tagged Ad-DN–AMPK-α1 and were exposed to 40 or 120 
mmHg CO2 for 30 min. Na,K-ATPase at the plasma membrane was determined as described above. Mean ± SEM. n = 4. Representative Western 
blots of the Na,K-ATPase-α1 at the plasma membrane, total protein abundance, and level of HA-tagged AMPK expression are shown. (C) ATII 
cells were treated with 2 mM AICAR for 30 or 60 min or with vehicle for 60 min, and the Na,K-ATPase at the plasma membrane was determined 
as above. Representative Western blots of Na,K-ATPase-α1 at the plasma membrane and total protein abundance are shown. (D) ATII cells were 
infected with Ad-null (50 pfu/cell) or a GFP-tagged Ad-CA–AMPK-α (2, 10, or 50 pfu/cell), and the amount of Na,K-ATPase was determined as 
described. Representative Western blots of Na,K-ATPase-α1 at the plasma membrane, total protein abundance, and expression GFP CA-AMPK 
are shown. Typical phase-contrast (PC) and GFP images of infected cells are shown. Mean ± SEM. n = 4. *P < 0.05; **P < 0.01.
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mammals, the protein kinase LKB1 and CaMKK-β, both of which 
phosphorylate AMPK at Thr172 (27). While CaMKK-β is expressed 
in both primary rat ATII and human epithelial A549 cells, LKB1 is 
found in rat ATII cells but not in A549 cells (Figure 5C), confirming 
previous reports that A549 cells lack LKB1 (28, 29). Exposing either 
cell type to high CO2 levels resulted in similar activation of AMPK 
(Figure 5, A and B), suggesting a role for CaMKK-β. Furthermore, 
preincubation of either primary rat ATII or A549 cells with STO-609, 
a CaMKK-α and -β inhibitor, decreased baseline phosphorylation of 
AMPK at Thr172, and high pCO2 did not increase AMPK phosphor-
ylation (Figure 5, A and B). To confirm that CaMKK-β was the kinase 
upstream of AMPK during hypercapnia, a siRNA approach was uti-
lized to knock down CaMKK-β expression in A549 cells. Silencing 
of CaMKK-β was confirmed by immunoblot, as illustrated in Figure 
5D. Incubation of A549 cells with the CaMKK-β siRNA decreased 
the protein content by approximately 82% as compared with the 
control with the scrambled siRNA sequence. Similar to the effects 
of STO-609, baseline AMPK phosphorylation was barely detectable 
and remained unchanged upon exposure to high pCO2 (Figure 5D).
Role of AMPK in hypercapnia-induced inhibition of AFR. To investi-
gate whether AMPK mediated the hypercapnia-induced impair-
ment of AFR, rat lungs were exposed to high pCO2 in the presence 
of the AMPK inhibitor compound C or vehicle alone. Consistent 
with our findings in ATII cells, the CO2-induced impairment of 
AFR was prevented in rat lungs pretreated with compound C 
(Figure 6A), without any effect on the passive movement of 
solutes (Figure 6B). Furthermore, when animals were infected 
with DN–AMPK-α1 adenoviruses and rat lungs were exposed 
to high pCO2 levels 7 days following adenoviral infection, the 
CO2-induced impairment of AFR was also prevented without 
altering passive paracellular permeability for solutes (Figure 6, 
C and D). Histological examination of the rat lungs 7 days after 
infection with null or DN–AMPK-α1 adenoviruses revealed no 
injury compared with sham-treated lungs, as previously report-
ed (30, 31). In these lungs, overexpression of DN–AMPK-α1 was 
observed throughout the alveolar epithelium, as assessed by 
immunohistochemistry and Western blot analysis of peripheral 
lung tissue (Figure 6, E and F).
Figure 3
AMPK is upstream of PKC-ζ in the CO2-induced 
signaling cascade in ATII cells. (A) ATII cells were 
exposed to 40 (Ctrl for 15 min) or 120 mmHg CO2 for 
the indicated times. PKC-ζ was immunoprecipitated 
and incubated with MBP and [γ−32P]ATP. A repre-
sentative autoradiograph of the phosphorylated 
MBP and a Western blot of the immunoprecipitated 
PKC-ζ are shown. The right lane in the autoradio-
graph shows the result when the kinase assay was 
performed in the absence of MBP. n = 4 (B) ATII 
cells were exposed to 40 or 120 mmHg CO2 for 
5 min in the presence or absence of compound C. 
PKC-ζ translocation was assessed as described in 
Methods. Representative Western blots for PKC-ζ 
and the loading control E-cadherin (a membrane 
protein) are shown. (C) ATII cells were infected 
with Ad-null or HA-tagged Ad-DN–AMPK-α1 and 
exposed to 40 or 120 mmHg CO2 for 5 min. PKC-ζ 
translocation was determined as described above. 
Representative Western blots for PKC-ζ and E-cad-
herin are shown. (D) ATII cells were treated with 
2 mM AICAR for the indicated times or with vehicle 
for 30 min, and translocation of PKC-ζ was deter-
mined as described above. Representative Western 
blots for PKC-ζ and E-cadherin are illustrated. (E) 
ATII cells were exposed to 40 or 120 mmHg CO2 
for 5 min in the presence or absence of bisindolyl-
maleimide I (Bis; 10 μM, 30 min preincubation) or 
a myristoylated peptide inhibitor of PKC-ζ (15 μM, 
30 min preincubation). pAMPK-α and total AMPK-α 
were determined by Western blot. Graph repre-
sents the pAMPK/AMPK ratio. Representative 
Western blots of pAMPK-α and total AMPK-α are 
shown. (F) ATII cells were infected with Ad-null or 
Ad-DN–PKC-ζ and exposed to 40 or 120 mmHg 
CO2 for 5 min. pAMPK-α and total AMPK-α were 
measured by Western blot. Graph represents the 
pAMPK/AMPK ratio. Representative Western 
blots of pAMPK-α and total AMPK-α and PKC-ζ in 
whole cell lysates are shown. Mean ± SEM. n = 4. 
*P < 0.05; **P < 0.01.
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Long-term exposure of rats to hypercapnia impairs AFR. We measured 
AFR in rats maintained in an atmosphere that consisted of 10% 
CO2, 21% O2, and balanced N2 for up to 7 days, as described in 
Methods. As shown in Figure 7A, AFR was markedly reduced (simi-
lar to 1 hour of ex vivo hypercapnia) after 3 and 7 days of exposure 
to high CO2 levels, without deleterious effects on passive movement 
of small solutes across the alveolar epithelium (Figure 7B). In line 
with these findings, exposure of isolated ATII cells to prolonged 
high CO2 resulted in a sustained decrease of plasma membrane 
Na,K-ATPase protein abundance (Figure 7C), suggesting that even 
though the activation of AMPK is transient, the downstream effects 
on Na,K-ATPase and AFR inhibition are sustained.
β-adrenergic receptor agonist and a cAMP analog ameliorate the hyper-
capnia-induced inhibition of AFR. To investigate whether β-adrener-
gic receptor and cAMP activation could prevent or overcome the 
hypercapnia-induced impairment of AFR, rat lungs were exposed 
to high pCO2 in the presence of isoproterenol or 8-bromo-cAMP 
(8Br). Importantly, either pretreatment with isoproterenol or 8Br 
significantly ameliorated the hypercapnia-induced reduction 
of AFR (Figure 8, A and B) without effecting changes on passive 
movement of small solutes (data not shown). Moreover, when 
lungs were first exposed to hypercapnia and then treated with iso-
proterenol, there was an amelioration of the hypercapnia-induced 
impairment of AFR (Figure 8C).
Discussion
Here we provide evidence that AECs sense elevated CO2 levels, result-
ing in very rapid activation of AMPK. The signaling cascade initiated 
Figure 4
CO2-induced activation of AMPK is Ca2+ dependent. (A) A represen-
tative trace of Ca2+ influx into ATII cells exposed to high CO2 levels 
is illustrated. Fura-2–loaded cells were initially perfused with media 
containing 40 mmHg CO2, and then perfusion was switched to 120 
mmHg CO2 while pHe was maintained at 7.4. Changes in [Ca2+]i are 
expressed as the F340/F380 ratio. n = 3. (B) ATII cells were exposed 
to 40 (white bars) or 120 (black bars) mmHg CO2 (pHe 7.4) for 5 min 
in the presence or absence of BAPTA-AM (20 μM, 20-min preincuba-
tion). pAMPK-α and total AMPK-α were determined by Western blot. 
Graph represents the pAMPK/AMPK ratio. Values are expressed as 
mean ± SEM. n = 4. **P < 0.01. Representative Western blots of 
pAMPK-α and total AMPK-α are shown.
Figure 5
CO2-induced activation of AMPK is mediated by CaMKK-β 
in ATII and A549 cells. (A and B) ATII (A) and A549 
cells (B) were exposed to 40 (white bars) or 120 (black 
bars) mmHg CO2 (pHe 7.4) for 5 min in the presence or 
absence of STO-609 (20 μg/ml, 30 min preincubation). 
pAMPK-α and total AMPK-α were determined by West-
ern blot. Graphs represent pAMPK/AMPK ratios. Val-
ues are expressed as mean ± SEM. n = 4. **P < 0.01; 
###P < 0.001 compared with untreated cells exposed to 
40 or 120 mmHg CO2. (C) Expression levels of LKB1 
and CaMKK-β in rat ATII and A549 cells are depicted in 
representative Western blots. Equal amounts of protein 
were loaded in each lane. Homogenates of rat kidney 
and rat cerebrum are shown on the left lane as positive 
controls for LKB1 and CaMKK-β, respectively. (D) A549 
cells were transfected with siRNA against CaMKK-β or 
scrambled siRNA, and 48 h later cells were exposed to 
40 (white bars) or 120 (black bars) mmHg CO2 (pHe 7.4) 
for 5 min. pAMPK-α and total AMPK-α were determined 
by Western blot. Graph represents the pAMPK/AMPK 
ratio. Values are expressed as mean ± SEM. n = 4. 
**P < 0.01 compared with control values; ###P < 0.001 
compared with both 40 and 120 mmHg CO2 controls.
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by high pCO2 is Ca2+ dependent and involves CaMKK-β. Activation 
of AMPK leads to PKC-ζ activation, which triggers the endocytosis 
of the Na,K-ATPase from the plasma membrane and results in AFR 
inhibition, an important function of the alveolar epithelium.
The concept of CO2 sensing was first reported in plants, which 
regulate CO2 uptake from the atmosphere during photosynthesis 
to maintain adequate carbon import, where as a consequence of 
specific signaling events, stomatal opening or closing is regulated 
by CO2 levels (32, 33). A CO2 sensor has also been proposed in 
Drosophila melanogaster as well as some fungal pathogens, which are 
exposed to dramatically different CO2 concentrations during infec-
tions and are able to adapt very rapidly to approximately 150-fold 
increases in CO2 levels (34). Furthermore, central and peripheral 
chemoreception of CO2 in mammalian neurons, such as special-
ized brainstem neurons and the carotid body glomus cells, were 
described several decades ago (reviewed in refs. 35, 36). It has also 
been proposed that CO2 and pH may independently modulate the 
activity of carotid body glomus cells in rabbits (37). In contrast, 
the mechanisms by which nonexcitable mammalian cells sense 
and respond to high CO2 levels have not been elucidated.
Here we report that elevated CO2 levels activate AMPK very rap-
idly and independently of pH (Figure 1, A and B). Once activated, 
AMPK upregulates energy-generating pathways while inhibiting 
energy-consuming events, thereby promoting cellular adapta-
tion to stressful conditions (16). Since membrane transport pro-
cesses consume a large proportion of cellular ATP, we reasoned 
that stimuli-activating AMPK may lead to the downregulation of 
Na,K-ATPase (38). Indeed, AMPK has been reported to inhibit the 
ion transporters ENaC and cystic fibrosis transmembrane conduc-
tance regulator Cl– channel  in the mammalian epithelium (18, 
19). Furthermore, in a recent study, pharmacological activation of 
AMPK resulted in a significant decrease of amiloride- and ouabain-
sensitive transepithelial Na+ transport across H441 cell monolayers 
(20).We used a specific inhibitor of AMPK and a genetic approach 
to knock down AMPK function, both of which prevented the CO2-
induced Na,K-ATPase endocytosis (Figure 2, A and B). Importantly, 
Figure 6
AMPK mediates the hypercapnia-induced 
impairment of AFR in rat lungs. (A) Isolat-
ed rat lungs were perfused for 1 h with 40 
mmHg CO2 (pHe 7.4; white bars) or with 
approximately 60 mmHg CO2 (pHe 7.2; 
black bars) in the presence or absence 
of compound C (20 μM, 30 min prein-
cubation), and AFR was measured as 
described in the supplemental material. 
Bars represent the mean ± SEM. n = 5. 
**P < 0.01. (B) Passive fluxes of 22Na+ 
(black bars) and 3H-mannitol (white 
bars) were measured as described in the 
supplemental material. Data represent 
the mean ± SEM. n = 5. (C) Isolated rat 
lungs from animals infected with surfac-
tant (sham), Ad-null, or Ad-DN–AMPK-α1 
were perfused for 1 h with 40 mmHg CO2 
(pHe 7.4; white bars) or with 60 mmHg 
CO2 (pHe 7.2; black bars), and AFR was 
measured as described in detail in the 
supplemental material. Bars represent the 
mean ± SEM. n = 5. **P < 0.01. (D) Pas-
sive fluxes of 22Na+ (black bars) and 
3H-mannitol (white bars) were measured 
as described in the supplemental mate-
rial. Data represent the mean ± SEM. 
n = 5. (E) H&E staining, phase con-
trast (PC), and GFP images after HA 
immunohistochemistry of peripheral lung 
tissues from sham and Ad-null– and Ad-
DN–AMPK-α1–infected rats are shown. 
(F) Representative Western blots of HA-
tagged AMPK and actin (as a loading 
control) are shown from peripheral lung 
tissue homogenates from sham and Ad-
null– and Ad-DN–AMPK-α1–infected rats.
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the overexpression of DN–AMPK-α in the alveolar epithelium pre-
vented the hypercapnia-induced impairment of AFR (Figure 6). 
Although we cannot exclude that the AMPK-α2 subunit may also 
participate in the CO2-induced signaling pathway, it appears that 
the AMPK-α1 subunit plays a prominent role in the signaling initi-
ated by high pCO2 levels.
Since we have previously described that the endocytosis of the 
Na,K-ATPase requires phosphorylation of the Na+ pump at Ser18 
by PKC-ζ (10, 21), we hypothesized that PKC-ζ might be regulated 
by AMPK. CO2 caused time-dependent PKC-ζ activation, which 
was prevented by pharmacological inhibitors or genetic modu-
lation of AMPK activity (see Figure 3). In contrast, inhibition of 
PKC-ζ had no effect on AMPK activation upon CO2 stimulation 
(Figure 3, E and F). We also found that treatment of ATII cells 
with AICAR, a chemical activator of AMPK, resulted in PKC-ζ acti-
vation (Figure 3B), similar to the effects of high pCO2. AICAR is 
taken up by cells, where it is metabolized to AICA-ribotide, which 
mimics the effect of AMP on AMPK (39, 40), and therefore, it is not 
surprising that the AICAR-induced activation of PKC-ζ occurred 
later (30 min; Figure 3B) than activation of PKC-ζ by CO2 (5 min; 
Figure 3, A and C). Furthermore, AICAR treatment or overexpres-
sion of CA–AMPK-α also resulted in Na,K-ATPase endocytosis in 
AECs (Figure 2, C and D), suggesting that activation of AMPK is 
not only necessary for the high CO2-induced endocytosis of the 
Na,K-ATPase, but that it is sufficient to downregulate the Na+ 
pump. Collectively, these data suggest that activation of AMPK 
by CO2 resulted in downregulation of the Na,K-ATPase via PKC-ζ 
phosphorylation of the Na+ pump. Interestingly, exposure of AECs 
to hypoxia or thrombin also promotes Na,K-ATPase endocytosis 
by the action of PKC-ζ (10, 13), and both have been recently pro-
posed as potent activators of AMPK (41, 42). Thus it is possible for 
AMPK to be the common pathway in response to multiple stimuli 
that regulate the Na,K-ATPase in the alveolar epithelium.
ROS have been reported to act as intracellular messengers and 
activate PKC-ζ (10, 43), and recently it has been suggested that 
CO2 may interact with ROS (44). However, we did not observe 
changes in intracellular ROS, nor in the cytosolic or mitochon-
drial compartments when AECs were exposed to high CO2 levels. 
Furthermore, pretreatment of cells with the antioxidant Eukarion 
134 had no effect on the CO2-induced endocytosis of Na,K-ATPase 
from the plasma membrane. Thus we reason that the CO2-induced 
and PKC-ζ-mediated effects on the Na,K-ATPase were indepen-
dent of ROS, which is distinct from previously reported stimuli 
that impair Na,K-ATPase function via PKC-ζ phosphorylation in 
the alveolar epithelium (10, 13, 45).
In mammals, LKB1 and CaMKK-β have been identified as 
upstream kinases of AMPK, since both kinases can phosphorylate 
Thr172 and thus activate AMPK (22, 27, 46–49). While phosphor-
ylation of Thr172 by LKB1 requires an increase in AMP (50, 51), 
the phosphorylation of Thr172 by CaMKK-β is independent of 
AMP levels and is triggered by a rise in intracellular Ca2+ (29, 42, 
47, 48, 52). We found that exposing AECs to high pCO2 initiated 
a rapid and transient influx of Ca2+ into the cells (Figure 4A) and 
that AMPK activation by high CO2 concentrations was prevented 
by the intracellular Ca2+-chelating agent, BAPTA-AM (Figure 4B), 
suggesting that the CO2-induced signaling pathway was depen-
dent upon intracellular Ca2+. Since CaMKK-β–mediated stimu-
lation of AMPK required an increase in intracellular Ca2+ levels, 
we hypothesized that CaMKK-β may be the upstream kinase 
induced by high pCO2. Indeed, the CaMKK inhibitor STO-609 
decreased the baseline AMPK activity and prevented activation 
of the AMPK upon high CO2 exposure in ATII cells (Figure 5A). 
Moreover, identical experiments performed in human epithelial 
Figure 7
Long-term exposure of rats to hypercapnia results in sustained impair-
ment of AFR. (A) Rats were maintained in room-temperature air (Ctrl) 
or at 10% CO2 and 21% O2 for 3 or 7 days and compared with isolated 
rat lungs that were perfused for 1 h with approximately 60 mmHg CO2, 
and AFR was measured as described in the supplemental material. 
Bars represent the mean ± SEM. n = 5. **P < 0.01. (B) Passive fluxes 
of 22Na+ (black bars) and 3H-mannitol (white bars) were measured as 
described above. Data represent the mean ± SEM. n = 5. (C) ATII 
cells were exposed to 40 (white bars) or 120 (black bars) mmHg CO2 
(pHe 7.4) for the indicated times. The Na,K-ATPase protein abun-
dance at the plasma membrane was determined by biotin-streptavi-
din pull-down and subsequent Western blot analysis. Bars represent 
the mean ± SEM. n = 4. **P < 0.01. Representative Western blots of 
Na,K-ATPase α1-subunit at the plasma membrane and total protein 
abundance are shown. White line indicates that lanes were run on the 
same gel but were noncontiguous.
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A549 cells, which lack LKB1 (28, 29) but express CaMKK-β, and in 
ATII cells, which express both kinases, revealed a comparable acti-
vation of AMPK by CO2. Similarly, pretreatment with the CaMKK 
inhibitor prevented AMPK activation by high CO2 in A549 cells 
(Figure 5B), and when these cells were transfected with siRNA to 
silence CaMKK-β, both baseline and high CO2-induced activity 
of AMPK were nearly undetectable (Figure 5D). It has been well 
established that activation of AMPK is transient in CaMKK-β– 
mediated responses and returns to baseline levels when the 
intracellular Ca2+ levels fall (42, 47, 53), while AMPK activation via 
LKB1 (which appears to be constitutively active) is rather sustained 
(46). Consistent with other CaMKK-β–dependent responses, 
activation of AMPK by elevated CO2 levels was also rapid and 
transient. These data suggest that the high CO2-induced activa-
tion of AMPK was mediated by CaMKK-β independently of LKB1 
signaling. Interestingly, the CO2-sensitive brainstem neurons and 
glomus cells also adapt to hypercapnia via an increase in [Ca2+]i 
(37, 54, 55), thus it is possible that CaMKK-β and AMPK are also 
involved in CO2 sensing in excitable cells.
We present evidence that in AECs, high pCO2 levels increase 
the [Ca2+]i, which results in activation of CaMKK-β, leading to 
AMPK activation. The elevation of intracellular Ca2+ levels can 
regulate a broad spectrum of cellular processes through precise 
spatial and temporal regulation of the Ca2+ signal (56–58). There 
are many examples of different cell types that utilize distinct 
signaling mechanisms to increase intracellular Ca2+ in a stimu-
lus-specific manner (58). For example, in fetal AECs, elevation of 
intracellular Ca2+ by β-adrenergic receptor activation stimulation 
leads to the activation of the amiloride-sensitive, nonselective 
cation channel, which contributes to the clearance of lung fluid 
(59, 60), whereas, as we demonstrate in this manuscript, during 
hypercapnia, increased [Ca2+]i activates CaMKK-β and AMPK, 
leading to Na,K-ATPase downregulation and inhibition of AFR. 
These contrasting effects of Ca2+ signaling might be attributed to 
alternative sources of Ca2+ and/or the compartmentalized loca-
tion and strength of the signal. The source of Ca2+ in the high 
pCO2 response warrants further studies.
An important function of the alveolar epithelium is to maintain 
optimal gas exchange. Thus to keep the alveoli “dry” and exchange 
O2 and CO2, AECs reabsorb the fluid that moves into the airspaces. 
This is achieved largely by the activity of ENaC and the Na,K-
ATPase, contributing to active Na+ transport across the alveolar 
epithelium (8, 9). We observed that hypercapnia impaired AFR 
by inhibiting Na,K-ATPase function. Importantly, hypoxia also 
diminishes AFR by downregulating both ENaC (61, 62) and Na,K-
ATPase (10, 63). Thus both hypercapnia and hypoxia, the 2 key 
components of acute respiratory failure, have deleterious effects 
on alveolar epithelial function and thereby might impair the reso-
lution of pulmonary edema and thus the recovery of patients with 
acute lung injury (64). Importantly, both the β-adrenergic agonist 
isoproterenol and the cAMP analog 8Br ameliorated the deleteri-
ous effects of hypercapnia on AFR. Indeed, β-adrenergic receptor 
agonists and cAMP are emerging as exciting new avenues for the 
management of patients with acute lung injury (65). These agents 
have been shown to overcome or prevent the effects of experimen-
tal acid-induced lung injury (66), hydrostatic edema (67), ventila-
tor-associated lung injury (68), and hypoxia (11, 61, 62).
We have also performed studies to address the effects of pro-
longed hypercapnia on alveolar epithelial function, as a prolonged 
exposure would more accurately mimic clinical situations. We have 
found that both short- and long-term hypercapnia (at levels simi-
lar to those observed in patients with chronic obstructive pulmo-
nary disease and permissive hypercapnia) resulted in comparable 
alveolar epithelial dysfunction (see Figure 7). These data suggest 
that hypercapnia may contribute to disease states in patients with 
increased CO2 levels.
In summary, we provide evidence that AECs sense elevated CO2 
levels, initiating an intracellular Ca2+–dependent signaling path-
way that involves the activation of CaMKK-β, AMPK, and PKC-ζ, 
triggering the endocytosis of Na,K-ATPase molecules and thus 
impairing AFR, an essential function of the alveolar epithelium. 
These results are of particular pathophysiological significance, 
given that the mammalian alveolar epithelium is the site of CO2 
elimination. Further studies are warranted to elucidate the mecha-
nisms by which the alveolar epithelium is affected by hypercapnia 
in patients with lung disease.
Figure 8
The hypercapnia-induced impairment of AFR in rat lung is amelio-
rated by isoproterenol and 8Br. (A) Isolated rat lungs were perfused 
for 1 h with 40 mmHg CO2 in the absence (Ctrl) and then for 1 h in 
the presence of isoproterenol (1 μM, ISO), after which perfusion was 
switched to approximately 60 mmHg CO2 in the continuous presence 
of isoproterenol, and AFR was measured as described in the supple-
mental material. Bars represent the mean ± SEM. n = 5. **P < 0.01. 
(B) Isolated rat lungs were perfused for 1 h with 40 mmHg CO2 in the 
absence and then for 1 h in the presence of 8Br (100 μM), after which 
perfusion was switched to approximately 60 mmHg CO2 in the con-
tinuous presence of 8Br, and AFR was measured as indicated above. 
Bars represent the mean ± SEM. n = 5. **P < 0.01. (C) Isolated rat 
lungs were perfused for 1 h with 40 mmHg CO2, and then perfusion 
was switched to approximately 60 mmHg for 1 h in the absence and 
then for 1 h in the presence of isoproterenol (1 μM). AFR was mea-
sured as described in the supplemental material. Bars represent the 
mean ± SEM. n = 5. **P < 0.01.
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Methods
Reagents. All cell culture reagents were from Mediatech Inc. 22Na+ was from 
GE Healthcare. 3H-mannitol was from PerkinElmer. The myristoylated 
PKC-ζ peptide inhibitor was from Biomol International. BAPTA-AM was 
from Sigma-Aldrich. siRNA against CaMKK-β was from Qiagen. Lipo-
fectamine RNAiMAX and Opti-MEM I reduced serum medium were from 
Invitrogen. The inhibitor of CaMKK, STO-609 (69), was from Calbiochem. 
A monoclonal antibody directed against the Na,K-ATPase α1 subunit 
(clone 464.6) and myelin basic protein (MBP) were from Upstate Biotech-
nology. Antibodies against PKC-ζ, GFP, and LKB1 (Ley37D/G6) were from 
Santa Cruz Biotechnology Inc. All other primary antibodies were from Cell 
Signaling. Secondary goat anti-mouse HRP was from Bio-Rad, and goat 
anti-rabbit HRP was from Cell Signaling. All other chemicals were pur-
chased from Calbiochem.
Animals. Pathogen-free adult male Sprague-Dawley rats were from Har-
lan. Animals were provided with food and water ad libitum, were main-
tained on a 12-hour light/12-hour dark cycle and were handled according 
to NIH guidelines and the Northwestern University Animal Care and Use 
Committee–approved experimental protocols.
Isolation and culture of AECs. Type II AECs were isolated from the lungs of 
Sprague-Dawley rats weighing 200–225 g, as previously described (31). The 
day of isolation and plating was designated culture day 0. All experiments 
were conducted on days 2 or 3. A549 cells (ATCC, CCL 185) were grown in 
DMEM supplemented with 10% fetal bovine serum and 100 U/ml peni-
cillin, 100 μg/ml streptomycin. Experiments were performed on subcon-
fluent monolayers of A549 cells. All cells were incubated in a humidified 
atmosphere of 5% CO2/95% air at 37°C.
CO2 media and CO2 exposure. For the different experimental conditions, 
initial solutions were prepared with DMEM-Ham’s F-12 medium-Tris base 
(3:1:0.5) containing 10% fetal bovine serum with 100 U/ml penicillin, and 
100 μg/ml streptomycin. The buffering capacity of the media was modi-
fied by changing its initial pH with Tris base in order to obtain a pH of 7.4 
at the various CO2 levels (pCO2 of 40, 60, 80, and 120 mmHg). In some 
experiments, modeling extracellular acidosis, an initial pH of 6.8 was used, 
resulting in a final pH of 7.2 and a pCO2 of 40 mmHg. The desired CO2 and 
pH levels were achieved by equilibrating the media overnight in a humidi-
fied chamber (C-Chamber; Biospherix Ltd.). The C-Chamber’s atmosphere 
was controlled with a PRO-CO2 Carbon Dioxide controller (Biospherix). 
In this chamber, cells were exposed to the desired pCO2 while maintaining 
21% O2 balanced with N2. Prior to and after CO2 exposure, pH, pCO2, and 
pO2 levels in the media were measured using a Stat Profile pHOx blood gas 
analyzer (Nova Biomedical). Experiments were started by replacing culture 
media with the CO2-equilibrated media and incubating in the C-Chamber 
for the desired time. Normoxic conditions were consistent over the course 
of all experiments.
Adenoviral infection of ATII cells. Day 2 ATII cells, plated on 60-mm cell 
culture dishes were incubated with Ad-null (20 or 50 pfu/cell) or with an 
Ad-DN kinase-dead (K45R) variant of the AMPK-α1 subunit (Ad-DN–
AMPK-α1; 20 pfu/cell) (70) or with a constitutively active AMPK-α variant 
(Ad-CA–AMPK-α), in which Thr172 was substituted with aspartate in the 
truncated 1-312 AMPK-α subunit (a generous gift from Kenneth Walsh, 
Boston University, Boston, Massachusetts, USA; 2, 10, or 50 pfu/cell) (71) 
or with an adenovirus expressing a DN PKC-ζ (Ad-DN–PKC-ζ; Cell Bio-
labs) for 2–4 h in 500 μl DMEM. After the 2- to 4-h incubation period, 
1.5 ml of DMEM supplemented with 10% fetal bovine serum, 100 U/ml 
penicillin, and 100 μg/ml streptomycin was added to the cell culture plates, 
and experiments were performed 24 h later.
Transfection of A549 cells with siRNA. A549 cells were plated in 60-mm cell 
culture dishes and transfected with 60 pmol siRNA duplex using Lipo-
fectamine RNAiMAX (Invitrogen) as recommended by the manufacturer, 
and experiments were performed 48 h later. The following siRNA were 
applied to target CaMKK-β: 5′-CGAUCGUCAUCUCUGGUUAdTdT-3′ 
and 5′-UAACCAGAGAUGACGAUCG-3′ (sense and antisense, respectively). 
As a nonsilencing negative control, 5′-UUCUCCGAACGUGUCACGUdT-
dT-3′ (sense) and 5′-ACGUGACACGUUCGGAGAAdTdT-3′ (antisense) 
were applied (all from Qiagen).
Biotinylation of cell surface proteins. Cells were labeled for 20 min using 
1 mg/ml EZ-link NHS-SS-biotin (Pierce Biotechnology), and surface pro-
teins were pulled down with streptavidin-Sepharose beads (Pierce Bio-
chemical), as previously described (10, 72, 73). Proteins were analyzed by 
SDS-PAGE and Western blot.
Western blot analysis. Protein concentration was quantified by Bradford 
assay (Bio-Rad), and proteins were resolved in 10%–15% polyacrylamide 
gels. Thereafter, proteins were transferred to nitrocellulose membranes 
(Optitran; Schleider & Schuell) using a semi-dry transfer apparatus (Bio-
Rad). Incubation with specific antibodies was performed overnight at 
4°C. Blots were developed with a chemiluminescence detection kit (Perkin-
Elmer), as recommended by the manufacturer. The bands were quantified 
by densitometric scanning (Image J 1.29X; NIH).
Cell fractionation. Cells were exposed to 40 or 120 mmHg CO2 at 37°C 
for 5 min, placed on ice, and washed twice with ice-cold PBS. Cells were 
scraped in homogenization buffer (1 mM EDTA, 1 mM EGTA, 10 mM Tris-
HCl, pH 7.5, 1 μg/ml leupeptin, 100 μg/ml TPCK, and 1 mM PMSF) and 
homogenized. Homogenates were centrifuged at 500 g to discard nuclei 
and debris, and the supernatant was centrifuged at 100,000 g for 1 h at 
4°C. The pellet containing the crude membrane fraction was resuspended 
in homogenization buffer supplemented with 1% Triton X-100 and centri-
fuged at 100,000 g for 30 min at 4°C. The supernatant was designated the 
1% Triton X-100–soluble membrane fraction (74).
PKC-ζ kinase assay. PKC-ζ activity was measured as previously described 
(75). Briefly, cell lysates were obtained after exposure to CO2, and PKC-ζ 
was immunoprecipitated by incubating overnight approximately 500 μg 
protein with 5 μl PKC-ζ antibody (Santa Cruz Biotechnology Inc.). Immu-
nocomplexes were pulled down with 50 μl Protein A/G agarose beads and 
then washed in lysis buffer. The immunoprecipitates were incubated with 
2 μg MBP, 10 μCi [γ-32P]–ATP, 100 μM ATP for 30 min at 30°C in 35 mM 
Tris, pH 7.5, 10 mM MgCl2, 5 mM EGTA, 1 mM CaCl2, and 10 mM β-glyc-
erolphosphate. The reactions were stopped by adding SDS sample buffer 
and boiling the samples. The proteins were separated by SDS-PAGE, and 
radiolabeled MBP was detected by autoradiography.
Measurement of intracellular Ca2+. The ATII cells were loaded with Fura-2/
AM (Invitrogen), which was used as a fluorescence indicator of intracellular-
free Ca2+ levels. Dye loading was performed in the standard buffer solution 
at pH 7.3 and supplemented with 2 μM Fura-2/AM. Cells were incubated 
with the dye-loading solution for 30 min at room temperature in the dark 
and further incubated for 30 min at room temperature to complete deester-
ification of the dye. Free Ca2+ concentrations were measured by digital video 
microfluorimetry using an intensified CCD camera coupled to the micro-
scope. Fura-2 dye was excited through 340-nm and 380-nm interference fil-
ters housed in a computer-controlled filter wheel. The fluorescence emitted 
was collected at 510 nm. The data acquisition of Fura-2 videoimaging was 
obtained using a Nikon TE2000 (Nikon Instruments Inc.) equipped with an 
environmental control system chamber (FCS2 system; Bioptechs Inc.) and a 
Plan Fluor 40× 1.30 oil objective (Nikon Instruments Inc). During imaging, 
the chamber was perfused with the specific culture media described above 
equilibrated at 40 or 120 mmHg CO2 (pHe 7.4). Images were collected with 
a Cascade camera TC285 EMCCD with on-chip multiplication gain (Pho-
tometrics) driven by MetaFluor Software (Molecular Devices Corp.). For 
all the experiments, exposure time was 100 ms, and to decrease phototoxic 
effects, 0.5 neutral filter was used. Changes in [Ca2+]i were expressed using 
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conventional F340/F380 ratio (the ratio of the Fura-2 fluorescence intensi-
ties measured at wavelengths of 340 nm and 380 nm).
Adenoviral infection of rats. Rats were anesthetized with 40 mg/kg nem-
butal i.p. and orally intubated with a 14-gauge plastic catheter prior to 
adenoviral infection. Three experimental groups were studied: sham-sur-
factant (n = 5), Ad-null (n = 5), and Ad-DN–AMPK-α1 (n = 5). A mixture of 
adenovirus (4 × 109 PFU) in a 50% surfactant (Forest Laboratories Inc.), 
50% dialysis buffer vehicle was administered in 4 aliquots of 250 μl. Rats 
were rotated 90° between instillations given at 5-min intervals. Immedi-
ately before instillation, a forced exhalation was achieved by circumferen-
tial compression of the thorax (31). Compression was relinquished after 
endotracheal instillation of 250 μl of virus/vehicle followed by 500 μl of 
air. Rats were allowed to recover before extubation. Infected animals were 
maintained in separate isolator cages for 7 days prior to conducting experi-
ments, as described previously (30, 31).
Long-term exposure of rats to hypercapnia. Pathogen-free male Sprague-
Dawley rats (300–325 g) were maintained in a continuously monitored 
Biospherix A Chamber for 3 or 7 days. The chamber atmosphere was con-
trolled with a ProOx model C-21 O2/CO2 controller combination (Bio-
spherix) at 10% CO2, 21% O2, with a temperature of 23–26°C and a relative 
humidity between 40% and 50%, and animals were allowed access to food 
and water ad libitum. No animals developed appreciable distress and were 
monitored visually by the investigators 3 times daily (at 8 am, 12 pm, and 
7 pm). The arterial pCO2 in the animals exposed to CO2 for 7 days was 
74 ± 6 mmHg. All experiments were approved by the Northwestern Univer-
sity Animal Care and Use Committee.
Isolated perfused rat lung model. The isolated lung preparation has been 
previously described in detail (12). A brief description of this methodol-
ogy is provided in Supplemental Data. During hypercapnia, pCO2 was 
69 ± 4 mmHg, resulting in a pH of 7.26 ± 0.02. The pO2 was constant in all 
experimental groups (160 ± 4 mmHg).
Immunohistochemistry. Longitudinal sections from fixed lungs were 
embedded in paraffin for immunohistochemical analysis. Primary anti-
body directed against the HA epitope (1:500 dilution) was added for 1 h at 
room temperature. Sections were washed with PBS prior to the addition of 
goat anti-mouse secondary antibody. Immunodetection was accomplished 
by 3,3′-diaminobenzidine staining for immunoperoxidase activity (Vector 
Elite ABC kit; Vector Laboratories). Sections were photographed using a 
digital photomicroscopy system (Spot II; Diagnostic Instruments).
Statistics. Data are expressed as mean ± SEM. Data were compared 
using analysis of variance adjusted for multiple comparisons with the 
Dunnet test. When comparisons were performed between 2 groups, sig-
nificance was evaluated by Student’s t test. A P value of less than 0.05 
was considered significant.
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